ACMD Unveils Ambitious 2026 Work Plan: Tackling Drug Misuse Head-On

The Advisory Council on the Misuse of Drugs (ACMD) reveals its comprehensive 2026 work program, focused on addressing critical challenges in drug policy and public health.
The Advisory Council on the Misuse of Drugs (ACMD), the leading independent expert body that advises the government on drug-related issues, has unveiled an ambitious work program for the year 2026. In a letter addressed to the Minister for Policing and Crime, the ACMD Chair outlined the organization's plans to tackle the growing challenge of drug misuse head-on.
At the core of the ACMD's 2026 agenda is a renewed focus on evidence-based policymaking, with a strong emphasis on public health and harm reduction strategies. The council will undertake a comprehensive review of existing drug laws and regulations, examining their effectiveness in addressing the root causes of addiction and reducing the negative societal impact of illicit drug use.
One of the key priorities for the ACMD in 2026 will be to investigate the potential therapeutic benefits of controlled substances, such as psychedelics, in the treatment of mental health disorders and addiction. The council aims to provide the government with robust scientific data to inform policy decisions in this emerging field of medical research.
Source: UK Government


